GEODE CAPITAL MANAGEMENT, LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$286,163
-9.4%
142,349
-8.5%
0.00%
Q2 2023$315,939
+2.0%
155,6350.0%0.00%
Q1 2023$309,713
+84290.5%
155,6350.0%0.00%
Q4 2022$367
-99.9%
155,635
-0.2%
0.00%
Q3 2022$321,000
+25.4%
155,870
+51.5%
0.00%
Q2 2022$256,000
+15.8%
102,911
+6.8%
0.00%
Q1 2022$221,000
+7.8%
96,326
+1.0%
0.00%
Q4 2021$205,000
-27.3%
95,3580.0%0.00%
Q3 2021$282,000
-7.5%
95,358
+8.8%
0.00%
Q2 2021$305,000
+5.9%
87,659
+10.7%
0.00%
Q1 2021$288,000
+119.8%
79,151
+141.7%
0.00%
Q4 2020$131,00032,7520.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SG3 Management, LLC 100,000$249,0000.03%
Murchinson Ltd. 50,593$126,0000.02%
Marquette Asset Management, LLC 17,318$43,0000.01%
SG3 Management, LLC 22,706$57,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$117,0000.00%
Tekla Capital Management LLC 32,461$81,0000.00%
BAILARD, INC. 35,000$87,0000.00%
GROUP ONE TRADING, L.P. 131,501$327,0000.00%
TWO SIGMA SECURITIES, LLC 10,238$25,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 882,900$2,198,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders